Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
99.3M
-
Shares change
-
+6.92M
-
Total reported value, excl. options
-
$3.23B
-
Value change
-
+$188M
-
Put/Call ratio
-
1.41
-
Number of buys
-
118
-
Number of sells
-
-87
-
Price
-
$32.54
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q4 2024
262 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q4 2024.
Legend Biotech Corp - COMMON STOCK (LEGN) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99.3M shares
of 367M outstanding shares and own 27.02% of the company stock.
Largest 10 shareholders include FMR LLC (13.4M shares), RA CAPITAL MANAGEMENT, L.P. (7.51M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.81M shares), HHLR ADVISORS, LTD. (5.98M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (5.71M shares), BlackRock, Inc. (4.61M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.5M shares), Invesco Ltd. (3.31M shares), BRAIDWELL LP (2.98M shares), and CITADEL ADVISORS LLC (2.9M shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.